HRP20170532T4 - Derivati kromanila za liječenje mitohondrijske bolesti - Google Patents

Derivati kromanila za liječenje mitohondrijske bolesti Download PDF

Info

Publication number
HRP20170532T4
HRP20170532T4 HRP20170532TT HRP20170532T HRP20170532T4 HR P20170532 T4 HRP20170532 T4 HR P20170532T4 HR P20170532T T HRP20170532T T HR P20170532TT HR P20170532 T HRP20170532 T HR P20170532T HR P20170532 T4 HRP20170532 T4 HR P20170532T4
Authority
HR
Croatia
Prior art keywords
compound
levels
cancer
alkyl
none
Prior art date
Application number
HRP20170532TT
Other languages
English (en)
Croatian (hr)
Inventor
Richard Hendrik Blaauw
Ruben Gerardus George Leenders
Jan Geert Sterk
Pedro Harold Han Hermkens
Original Assignee
Khondrion Ip B.V.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Khondrion Ip B.V. filed Critical Khondrion Ip B.V.
Priority claimed from EP13759838.9A external-priority patent/EP2872497B2/en
Publication of HRP20170532T1 publication Critical patent/HRP20170532T1/hr
Publication of HRP20170532T4 publication Critical patent/HRP20170532T4/hr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A61K8/498—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom having 6-membered rings or their condensed derivatives, e.g. coumarin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/08—Anti-ageing preparations
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/74—Biological properties of particular ingredients

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Gerontology & Geriatric Medicine (AREA)
  • Dermatology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
HRP20170532TT 2012-07-12 2013-07-12 Derivati kromanila za liječenje mitohondrijske bolesti HRP20170532T4 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201261670644P 2012-07-12 2012-07-12
EP12176128 2012-07-12
EP13759838.9A EP2872497B2 (en) 2012-07-12 2013-07-12 Chromanyl derivatives for treating mitochondrial disease
PCT/NL2013/050528 WO2014011047A1 (en) 2012-07-12 2013-07-12 Chromanyl derivatives for treating mitochondrial disease

Publications (2)

Publication Number Publication Date
HRP20170532T1 HRP20170532T1 (hr) 2017-06-16
HRP20170532T4 true HRP20170532T4 (hr) 2019-12-27

Family

ID=53577992

Family Applications (1)

Application Number Title Priority Date Filing Date
HRP20170532TT HRP20170532T4 (hr) 2012-07-12 2013-07-12 Derivati kromanila za liječenje mitohondrijske bolesti

Country Status (5)

Country Link
US (1) US9388156B2 (enExample)
CY (1) CY1119384T1 (enExample)
HR (1) HRP20170532T4 (enExample)
IN (1) IN2015MN00114A (enExample)
MX (1) MX364547B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX2019011692A (es) * 2017-04-05 2020-02-10 Khondrion Ip B V Nuevo tratamiento de enfermedades mitocondriales.
JP7405484B2 (ja) * 2017-11-22 2023-12-26 コンドリオン アイピー ビー．ブイ． うつ病及び片頭痛の治療に使用される新規化合物
US11672787B2 (en) * 2017-11-22 2023-06-13 Khondrion Ip B.V. Compounds as mPGES-1 inhibitors
EP3917509A4 (en) 2019-01-28 2022-11-09 Mitochondria Emotion, Inc. TRANS-4-HYDROXYCYCLOHEXYLPHENYLAMIDE MITOFUSIN ACTIVATORS AND METHODS OF USE THEREOF
AU2019427489B2 (en) 2019-01-28 2025-03-13 Mitochondria Emotion, Inc. Mitofusin activators and methods of use thereof

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR019190A1 (es) 1998-07-08 2001-12-26 Sod Conseils Rech Applic Derivados de 2-aminopiridinas, productos intermedios para su preparacion, medicamentos y composiciones farmaceuticas que los contienen y su uso para preparar medicamentos
WO2001081324A1 (de) 2000-04-25 2001-11-01 Schering Aktiengesellschaft Benzoxazin- und benzothiazin-derivate mit nos-inhibitorischen und antioxidativen eigenschaften
JP2002047272A (ja) 2000-07-26 2002-02-12 Dai Ichi Seiyaku Co Ltd ポリアミンアミド誘導体
EP3456707B1 (en) 2007-11-06 2020-04-15 PTC Therapeutics, Inc. 4- (p-quinonyl)-2-hydroxybutanamide derivatives for treatment of mitochondrial diseases

Also Published As

Publication number Publication date
US9388156B2 (en) 2016-07-12
HK1209425A1 (en) 2016-04-01
IN2015MN00114A (enExample) 2015-10-16
CY1119384T1 (el) 2018-02-14
MX2015000488A (es) 2015-04-08
US20150166501A1 (en) 2015-06-18
HRP20170532T1 (hr) 2017-06-16
MX364547B (es) 2019-04-30

Similar Documents

Publication Publication Date Title
HRP20170532T4 (hr) Derivati kromanila za liječenje mitohondrijske bolesti
UA110924C2 (uk) Мезоіонні пестициди
BRPI0508281A (pt) compostos, processo para a preparação dos mesmos, agente fungicida, semente, e, processo para o combate de fungos nocivos fitopatogênicos
MY168201A (en) Agricultural And Horticultural Fungicidal Composition
TW200734290A (en) Amide derivative and insecticide containing the same
PH12019502042A1 (en) Fungicidal composition and method for controlling plant diseases
BR0107811A (pt) Composição herbicida
WO2010005692A3 (en) Insecticidal cyclic carbonyl amidines
MX2010005649A (es) Compuestos novedosos como ligandos del receptor canabinoide y sus usos.
NZ593848A (en) Synthesis of 18f-radiolabeled styrylpyridines from tosylate precursors and stable pharmaceutical compositions thereof
MY155695A (en) Quinoxalinedione derivatives
BRPI0515081A (pt) derivados de fenilaminopirimidina como inibidores de bcr-abl cinase
BRPI0408353A (pt) composto, composição farmacêutica, métodos para o tratamento de neoplasias suscetìveis e para o tratamento de infecções virais, e, uso de um composto
MX2009012041A (es) Derivados de 1,3-dihidroimidazol-2-tiona como inhibidores de dopamina-beta-hidroxilasa.
MY145746A (en) Heterocyclic substituted pyridine derivatives and antifungal agent containing same
GEP20135959B (en) Aryl piperazine and their usage as alpha2c antagonists
CN103130769B (zh) 一种3-二氟乙氧基-吡唑酰胺类化合物及其应用
MX2009013581A (es) Derivados de 4-(n-azacicloalquil)anilidas como moduladores del canal de potasio.
Hershko Iron loading and its clinical implications
ATE553095T1 (de) Neue imidazolderivate, deren herstellung und deren verwendung als intermediate zur herstellung von arzneimitteln und pestiziden
TW200714598A (en) Urea derivatives, methods for their manufacture, and uses therefor
MA29258B1 (fr) Nouveaux derives d'oximes heterocycliques, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MX2015007116A (es) Nuevos derivados de 1,4-ditiina sustituida y su uso como fungicidas.
PH12014501181A1 (en) N- (4 -quinolinylmethyl) sulfonamide derivatives and their use as anthelmintics
MX2023009166A (es) Derivados de quinoxalina y sus usos.